Printer Friendly

Browse Macular degeneration topic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Opthea receives funding for OPT-302 trials, pre-commercialization activities. Aug 15, 2022 177
Cognition Therapeutics reports Q2 EPS (25c), consensus (32c). Financial report Aug 9, 2022 180
OliX Pharmaceuticals Receives IND Approval from FDA to Develop RNAi Therapeutic OLX10212 for Age-related Macular Degeneration. Aug 8, 2022 256
OliX Pharmaceuticals granted FDA approval to develop RNAi therapeutic for AMD. Aug 3, 2022 155
OliX Pharmaceuticals granted FDA approval to develop RNAi therapeutic for AMD. Aug 3, 2022 156
EyePoint Pharmaceuticals doses first patient in phase two 'Durasert and Vorolanib in Ophthalmology 2' EYP-1901 clinical trial. Aug 2, 2022 294
EyePoint Pharmaceuticals doses first patient in phase two 'Durasert and Vorolanib in Ophthalmology 2' EYP-1901 clinical trial. Aug 2, 2022 295
Control Some of Your AMD Risk. Etingin, Orli R. Jul 31, 2022 361
Reduce Your Risk of Age-Related Macular Degeneration: Eye exams are essential; the earlier AMD is diagnosed and treated, the less likely it is to cause blindness. Jul 31, 2022 750
Relationship of Retinal Vessel Caliber with Age-Related Macular Degeneration. Toulouie, Sara; Chang, Sean; Pan, Julia; Snyder, Kiersten; Yiu, Glenn Clinical report Jul 31, 2022 6300
Akari Therapeutics announces results from preclinical studys of PAS-nomacopan. Financial report Jul 28, 2022 716
LumiThera Acquires Assets of Diagnostic Tool Developer MacuLogix. Jul 27, 2022 222
LumiThera Acquires Assets of Diagnostic Tool Developer MacuLogix. Jul 27, 2022 245
Clearside Biomedical completes dosing in OASIS Phase 1/2a trial of CLS-AX. Jul 26, 2022 247
Apellis announces FDA acceptance, priority review of NDA for pegcetacoplan. Jul 19, 2022 177
EyePoint Pharmaceuticals reveals 12-month data from Phase 1 'Durasert and Vorolanib in Ophthalmology' (DAVIO) clinical trial assessing EYP-1901. Jul 18, 2022 384
EyePoint Pharmaceuticals reveals 12-month data from Phase 1 'Durasert and Vorolanib in Ophthalmology' (DAVIO) clinical trial assessing EYP-1901. Jul 18, 2022 383
Breakthrough treatment for Dry AMD Now available locally in Brigg, North Lincolnshire; ADVERTISING FEATURE New TREATMENT to help sufferers see better. Jul 15, 2022 307
Adverum Biotechnologies presents new data from OPTIC study during ASRS. Jul 15, 2022 397
EyePoint reports 'positive' 12-month data from Phase 1 trial of EYP-1901. Jul 15, 2022 312
Genentech announces new two-year data from TENAYA, LUCERNE studies. Jul 14, 2022 392
REGENXBIO completes enrolment in Cohort 5 of Phase II AAVIATE trial of RGX-314. Jul 11, 2022 212
REGENXBIO completes enrolment in Cohort 5 of Phase II AAVIATE trial of RGX-314. Jul 11, 2022 211
New group for blind in Callander. Jul 8, 2022 235
Sight loss group in Callander. Jul 6, 2022 235
DelSiTech and Iveric Bio sign licence agreement for development and commercialisation of sustained release Zimura. Jul 6, 2022 260
DelSiTech and Iveric Bio sign licence agreement for development and commercialisation of sustained release Zimura. Jul 6, 2022 261
DelSiTech and Iveric Bio sign licence agreement for development and commercialisation of sustained release Zimura. Jul 6, 2022 259
Adverum Biotechnologies completes IND amendment with FDA for LUNA trial. Jul 6, 2022 252
Iveric bio, DelSiTech in pact to develop sustained release Zimura. Jul 5, 2022 272
Iveric Bio, DelSiTech Enter Exclusive Agreement for Development of Sustained Release Zimura. Jul 5, 2022 564
Primary Vitreoretinal Lymphoma: A Retrospective Study of 20 Eyes. Luo, Jing-Yi; Yu, Shi-Tong; Xu, Xiao-Yu; Lin, Xian-Xuan; Luo, Rong-Jiang; Long, Chong-De Report Jul 1, 2022 5140
Effect of Intravitreal Anti-Vascular Endothelial Growth Factor Injection on Intraocular Pressure and Systemic Blood Pressure. Beenish Saleem, Muhammad Azeem Khizer and Asfandyar Khan Jun 30, 2022 2539
Drusen is not necessarily a sign of macular degeneration. Jun 20, 2022 541
Short Communication - Neuroprotective Effect of Excitatory Amino Acid Receptor Antagonist on Retina of Rat. Fan, Chuanfeng; Feng, Wenguo; Yang, Jingchang; Chen, Qingchao; Wang, Yu Report Jun 11, 2022 2085
Prescribing of low- versus high-cost Part B drugs in Medicare Advantage and traditional Medicare. Anderson, Kelly E.; Polsky, Daniel; Dy, Sydney; Sen, Aditi P. Report Jun 1, 2022 8158
The Role of Omega-3 and Antioxidant Nutrients in Age-Related Macular Degeneration: A Review Article. Kocyigit, Emine; Tek, Nilufer Acar Jun 1, 2022 5147
Outlook Therapeutics: FDA requests more information on ONS-5010 BLA. May 31, 2022 275
Stealth Biotherapeutics reports Phase 2 results of elamipretide in GA. Financial report May 23, 2022 205
Recent Advances and the Mechanism of Astaxanthin in Ophthalmological Diseases. Yang, Ming; Wang, Yanling May 20, 2022 8974
UK Grants Licence for Teva's Ophthalmology Biosimilar Ongavia. May 17, 2022 324
Unity Biotechnology reports Q1 EPS (28c), consensus (26c). Financial report May 10, 2022 173
The Relationship between Statin and Risk of Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis. Memarzadeh, Ezatollah; Heidari-Soureshjani, Saeid Report May 9, 2022 5737
Association between Cataract Surgery and Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis. Yang, Lihong; Li, Hongxun; Zhao, Xinheng; Pan, Ye May 5, 2022 5675
Unity Biotechnology presents on UBX1325 at ARVO 2022. May 5, 2022 322
Cognition presents preclinical findings on sigma-2 receptor modulators. May 3, 2022 225
Apellis announces longer-term data from DERBY, OAKS studies. May 2, 2022 324
Three eye conditions affecting your sight and how the Nuffield Health Guildford Hospital can help; Nuffield Health Guildford Hospital's dedicated enquiry team are on hand to discuss the process with you. By, Russ Taylerson May 2, 2022 950
2022 Issue 3 at a Glance. Ozdemir, Hakan May 1, 2022 913
Dry Eye and Meibomian Gland Dysfunction in Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Injections. Kiyat, Pelin; Palamar, Melis; Nalcaci, Serhad; Akkin, Cezmi May 1, 2022 3647
Survey of Intravitreal Injection Preferences for the Treatment of Age-Related Macular Degeneration and Macular Edema Among Members of the Turkish Ophthalmological Association. Karabas, V. Levent; Tokuc, Ecem Onder; Sermet, Figen May 1, 2022 3831
Mean Changes in Intraocular Pressure after Intravitreal Injection of Bevacizumab in Exudative Age Related Deneration and Proliferative Diabetic Retinopathy. Rebecca, Shafi Muhammad Jatoi, Fahad Feroz Shaikh and Muhammad Shahid Apr 30, 2022 2276
PharmAbcine reveals positive results from PMC-403 GLP toxicology study. Apr 27, 2022 170
PharmAbcine reveals positive results from PMC-403 GLP toxicology study. Apr 27, 2022 169
Vision for the future: Nonprofit Hadley in Winnetka helps people with failing eyesight navigate life. Kim Becker kbecker@dailyherald.com Apr 27, 2022 651
Samsara Vision to Initiate a US PMA Supplemental Study of the SING IMT, a New-Generation Technology for Age-Related Macular Degeneration. Apr 22, 2022 614
Unity Biotechnology doses first patient in ENVISION study of UBX1325. Apr 19, 2022 180
Efficacy and Safety of Antivascular Endothelial Growth Factor (Anti-VEGF) in Treating Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Meta-analysis. Yin, Xiaobei; He, Ting; Yang, Shanshan; Cui, Hui; Jiang, Wenlan Apr 15, 2022 6126
Real-World Cataract Surgery Complications and Secondary Interventions Incidence Rates: An Analysis of US Medicare Claims Database. Terveen, Daniel; Berdahl, John; Dhariwal, Mukesh; Meng, Qian Apr 6, 2022 4348
Adverum proceeds with IND amendment for wet AMD trial after FDA Type C feedback. Apr 6, 2022 245
A Novel Smartphone-Based Color Test for Detection of Color Vision Defects in Age Related Macular Degeneration. Karampatakis, Vassilios; Almaliotis, Diamantis; Karamitopoulos, Leonidas; Kalliris, George; Almpanid Mar 31, 2022 7449
Outlook Therapeutics submits BLA to US FDA for ONS-5010. Mar 31, 2022 259
Graybug Vision announces update on pipeline programs. Mar 30, 2022 568
Roche announces Vabysmo approved for nAMD and DME in Japan. Mar 28, 2022 166
Early OCT Angiography Changes of Macular Neovascularization in Patients with Exudative AMD Treated with Brolucizumab in a Real-World Setting. Rübsam, Anne; Rau, Saskia; Pilger, Daniel; Zeitz, Oliver; Joussen, Antonia M. Clinical report Mar 25, 2022 6395
Apellis announces long-term data from Phase 3 DERBY, OAKS studies. Mar 16, 2022 260
LumiThera completes debt financing agreement to support commercial activities. Mar 10, 2022 163
LumiThera completes debt financing agreement to support commercial activities. Mar 10, 2022 164
Nova MSC Collaborates with AMO and RHAZES to Bring its AI Deep Learning Technology, SELENA+ to Mainstream Adoption. Feb 21, 2022 894
Retinal Blood Vessels and Optic Disc Segmentation Using U-Net. David, S. Alex; Mahesh, C.; Kumar, V. Dhilip; Polat, Kemal; Alhudhaif, Adi; Nour, Majid Feb 14, 2022 7211
EyePoint Pharmaceuticals reveals updated interim data from 'Durasert and Vorolanib in Ophthalmology' phase one clinical trial of EYP-1901. Feb 14, 2022 323
EyePoint Pharmaceuticals reveals updated interim data from 'Durasert and Vorolanib in Ophthalmology' phase one clinical trial of EYP-1901. Feb 14, 2022 324
Know the ABCs of age-related macular degeneration. Submitted by American Society of Retina Specialists Feb 5, 2022 578
TESTS FOR EVERYDAY VISUAL FUNCTION IN AMD PATIENTS. Powell, Selina Feb 1, 2022 220
DIABETIC RETINOPATHY OR NOT? Bundy, David Feb 1, 2022 505
FDA Approves Genentech's Vabysmo, the First Bispecific Antibody for the Eye, to Treat Two Leading Causes of Vision Loss. Jan 31, 2022 549
Kriya Licenses Complement-Targeted Gene Therapies for the Treatment of Geographic Atrophy and Other Ocular Diseases. Jan 27, 2022 312
Gran bionic eye a UK 1st; Microchip under retina 'partially restores vision'. MARTIN BAGOT Jan 21, 2022 358
Gran bionic eye a UK 1st; Microchip under retina 'partially restores vision'. MARTIN BAGOT Health Editor Jan 21, 2022 365
Gran becomes first UK patient to be fitted with bionic eye in science breakthrough; The 88-year-old woman underwent an operation at Moorfield Eye Hospital in London, having a 2mm wide microchip under her retina. The chip offers the hope of partially restored vision. By, Martin Bagot Jan 21, 2022 353
Ribomic Posts Preliminary Topline Data from Phase 2 Trials of RBM-007 for Wet Age-Related Macular Degeneration. Clinical report Jan 3, 2022 438
LINEAGE & GENENTECH PARTNER ON RPE CELL THERAPY. Jan 1, 2022 533
Fixation Stability and Preferred Retinal Locus in Advanced Age-Related Macular Degeneration. Altinbay, Deniz; Idil, Sefay Aysun Clinical report Jan 1, 2022 4949
EFFECTS OF UNILATERAL INTRAVITREAL BEVACIZUMAB ON THE CONTRALATERAL EYE HAVING DIABETIC MACULAR EDEMA. Aziz Jan Bashir, Abdul Hannan, Salman Sohail Chaudhary, Sarah Zafar, Abdullah Naeem Syed and Syed Ha Dec 31, 2021 1802
EVALUATION OF CHOROID THICKNESS CHANGES AFTER UNEVENTFUL PHACOEMULSIFICATION SURGERY USING SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY AT A TERTIARY CARE EYE HOSPITAL. Aisha Rafique, Omar Zafar, Summaya Khan and Hassaan Javaid Dec 31, 2021 2672
Visual Outcome after Vitrectomy with Subretinal tPA Injection to Treat Submacular Hemorrhage Secondary to Age-Related Macular Degeneration or Macroaneurysm. Ali Said, Yasmin; Dewilde, Evelien; Stalmans, Peter Dec 30, 2021 4300
PQQ: Revitalizes Aging Energy Cells. McCulloch, Marsha Dec 22, 2021 2677
Fourth Case Of Retinal Tissue Restoration With OpRegen. Clinical report Dec 20, 2021 729
Lineage Establishes Exclusive Worldwide Collaboration with Genentech for the Development and Commercialization of OpRegen RPE Cell Therapy for the Treatment of Ocular Disorders. Dec 20, 2021 565
Significance of Hyperreflective Foci as an Optical Coherence Tomography Biomarker in Retinal Diseases: Characterization and Clinical Implications. Fragiotta, Serena; Abdolrahimzadeh, Solmaz; Dolz-Marco, Rosa; Sakurada, Yoichi; Gal-Or, Orly; Scuder Dec 17, 2021 9168
Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macular Degeneration. Huber, Anna Lena; Angermann, Reinhard; Nowosielski, Yvonne; Seifarth, Christof; Kralinger, Martina T Dec 15, 2021 4132
The value of eye health in the digital era. Nov 22, 2021 490
REGENXBIO Inc completes with AbbVie Collaboration and License Agreement. Nov 10, 2021 254
REGENXBIO Inc completes with AbbVie Collaboration and License Agreement. Nov 10, 2021 255
Adverum Biotechnologies reports Q3 EPS (39c), consensus (37c). Financial report Nov 4, 2021 179
Long-Term Outcome of Eyes with Vitrectomy for Submacular and/or Vitreous Hemorrhage in Neovascular Age-Related Macular Degeneration. Kawakami, Setsuko; Wakabayashi, Yoshihiro; Umazume, Kazuhiko; Usui, Yoshihiko; Muramatsu, Daisuke; A Nov 2, 2021 6066
MicroRNA-27a Promotes Oxidative-Induced RPE Cell Death through Targeting FOXO1. Ren, Chengda; Hu, Weinan; Wei, Qingquan; Cai, Wenting; Jin, Huizi; Yu, Donghui; Liu, Chang Report Nov 1, 2021 7974
Curacle and ThA(c)a Ink Licensing and Collaboration Agreement for the Development and Commercialization of Orally Administered Treatment for Diabetic Macular Edema and Wet-AMD. Oct 27, 2021 414
Experts warn of blindness due to diabetes. Oct 25, 2021 337
Experts warn of blindness due to diabetes. Oct 25, 2021 337
Diabetes eye disorders can lead to blindness: Experts. Oct 23, 2021 340
FDA approves Genentech's Susvimo. Oct 22, 2021 166
FDA Approves Genentech's Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet Age-Related Macular Degeneration. Oct 22, 2021 1244
Opthea announces patient enrollment for OPT-302 Phase 3 clinical program. Oct 19, 2021 179
EyePoint presents positive safety data from Phase 1 trial of EYP-1901. Oct 12, 2021 187
Ocuphire Pharma announces publications featuring Ref-1 protein. Oct 7, 2021 377
4D Molecular announces FDA clearance of IND application for 4D-150. Oct 6, 2021 301
Unity Biotechnology announces 12-week data from Phase 1 trial of UBX1325. Oct 5, 2021 402
Opthea opens patient recruitment in Europe for Phase 3 ShORe, COAST trials. Oct 4, 2021 218
Coherus Biosciences announces results from COLUMBUS-AMD trial. Oct 4, 2021 187
Investigation of Key Signaling Pathways Associating miR-204 and Common Retinopathies. Bereimipour, Ahmad; Satarian, Leila; Taleahmad, Sara Report Oct 4, 2021 6741
Regenxbio announces Suprachoroidal delivery of RGX-314 well tolerated. Oct 1, 2021 439
Graybug Vision reports analysis of data from ALTISSIMO Phase 2b trial. Sep 28, 2021 270
Outlook Therapeutics reports 12-month safety data from Phase 3 NORSE TWO trial. Sep 28, 2021 491
Clearside Biomedical completes dosing in Cohort 2 of Phase 1/2a of CLS-AX. Sep 21, 2021 189
Eye condition can increase dementia risk; in brief. Sep 14, 2021 341
AbbVie, Regenxbio announce partnership to develop and commercialize RGX-314. Sep 13, 2021 260
Apellis plans NDA for pegcetacoplan for GA to FDA after studies met endpoint. Sep 9, 2021 418
Alleye mobile app helps users detect visual distortion. Daily News Egypt Sep 1, 2021 346
PLANT PIGMENTS PROTECT AGAINST VISION LOSS. Downey, Michael Cover story Sep 1, 2021 2661
Hero Harry offers sight-loss support. Aug 25, 2021 442
Regeneron's ongoing phase 2 trial of 8mg dose of aflibercept met safety endpoint. Aug 24, 2021 264
Community service is keeping an eye on serious conditions. MARK SMITH Health correspondent mark.smith@walesonline.co.uk Aug 23, 2021 775
How to save your sight. Aug 10, 2021 707
Opthea expands global Phase 3 ShORe, COAST Wet AMD trials of OPT-302 to Canada. Aug 9, 2021 283
Polpharma Biologics Group JV Bioeq Has Submitted a Biologics License Application for Biosimilar Ranibizumab to the US Food and Drug Administration. Aug 9, 2021 442
Outlook Therapeutics reports 'positive' data from Phase 3 NORSE TWO trial. Aug 3, 2021 182
First Patient Dosed in US-based Phase 1 Clinical Trial of OTX-TKI for the Treatment of Wet Age-Related Macular Degeneration. Aug 2, 2021 550
Improvements In Patients With Dry AMD With Geographic Atrophy. Clinical report Aug 2, 2021 239
Don't Let Age-Related Macular Degeneration Steal Your Sight: Eye exams are essential; the earlier AMD is diagnosed and treated, the less likely it is to cause blindness. Aug 1, 2021 777
Roche's faricimab application accepted by US FDA. Jul 30, 2021 200
Roche's faricimab application accepted by US FDA. Jul 30, 2021 201
Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option. Qin, Shuqi; Dong, Ning; Yang, Ming; Wang, Jialin; Feng, Xue; Wang, Yanling Jul 30, 2021 13772
Iveric Bio Completes Patient Enrollment of GATHER2 Pivotal Clinical Trial of Zimura Ahead of Schedule. Jul 27, 2021 555
Iveric bio completes patient enrollment in clinical trial of Zimura. Jul 26, 2021 369
Unity Biotechnology to host investor call on Phase 1 trial of UBX1325. Jul 23, 2021 162
Adverum Biotechnologies no longer plans future development for DME in INFINITY. Jul 22, 2021 293
Iveric bio appoints Christopher Simms as Chief Commercial Officer. Jul 19, 2021 183
Polpharma Biologics JV Company, Bioeq, Has Entered Into a Commercialization Agreement for Biosimilar Ranibizumab. Jul 8, 2021 569
Iveric Bio Receives FDA Agreement Under Special Protocol Assessment for GATHER2 Phase 3 Clinical Trial of Zimura in Geographic Atrophy Secondary to Age-Related Macular Degeneration. Jul 7, 2021 783
Iveric bio receives FDA agreement under SPA for GATHER2 Phase 3 trial. Jul 6, 2021 424
Opthea's OPT-302 granted Fast Track designation for wet AMD. Jul 6, 2021 157
EyePoint reports 30-day safety results for all cohorts from DAVIO trial. Financial report Jul 6, 2021 223
Vision Improves In Some Advanced Dry AMD patients After Stem Cell Implant. Jul 5, 2021 682
I Can See Clearly Now: How to protect your vision. Chew, Emily Interview Jul 1, 2021 2572
MANAGEMENT OF LOW VISION IN PEOPLE WITH MYOPIC MACULAR DEGENERATION. Mufarriq Shah and Muhammad Tariq Khan Jun 30, 2021 3206
Ocular Therapeutix, Mosaic Biosciences team on macular degeneration. Jun 29, 2021 212
Samsung Bioepis, Biogen receive positive CHMP opinion for BYOOVIZ. Jun 25, 2021 156
Causes of blurry vision ... Etingin, Orli R. Jun 25, 2021 318
Iveric bio to present GATHER2 enrollment data, GATHER1 analyses. Jun 18, 2021 236
PanOptica Inks Licensing Agreement with Zhaoke Ophthalmology for PAN-90806 for the Treatment of Neovascular Eye Diseases in China, South Korea, and Southeast Asia. Jun 18, 2021 682
Clearside report 'positive' safety results from OASIS Phase 1/2a trial of CLS-AX. Jun 15, 2021 255
On the Horizon: New Treatments for Acute Macular Degeneration: Therapies may become more convenient for people with the condition. Jun 9, 2021 1081
Data affirms benefits of Bausch + Lomb formula. Jun 7, 2021 275
Companies Partner To Develop iPS Cell Therapies For Eye Diseases. Jun 7, 2021 370
Lineage Cell Therapeutics annonces new patients with retinal tissue restoration. Jun 1, 2021 251
OCTOPUS VISION TEST COULD HELP PINPOINT PATIENTS AT RISK OF AMD. Jun 1, 2021 222
Macula, magnifiers and more: This article describes the impact of visual impairment on patients with age-related macular degeneration and how this can be managed. Tooth, Cirta Jun 1, 2021 2436
Outlook Therapeutics provides recap of virtual Clinical Day. May 27, 2021 195
Bausch + Lomb announces positive new National Eye Institute Data regarding AREDS2 Nutrient Formula for advanced age-related macular degeneration. May 12, 2021 230
Bausch + Lomb announces positive new National Eye Institute Data regarding AREDS2 Nutrient Formula for advanced age-related macular degeneration. May 12, 2021 231
Ocugen presents new preclinical data on OCU200 at ARVO annual meeting. May 6, 2021 212
Adverum Biotechnologies presents long-term data from OPTIC trial of ADVM-022. May 2, 2021 221
Aflibercept Treatment Results and Association with Baseline Characteristics in Cases of Newly Diagnosed Neovascular Age-Related Macular Degeneration. Kiyat, Pelin; Mentes, Jale; Nalcaci, Serhad; Afrashi, Filiz; Baris, Mine Clinical report May 1, 2021 5170
The Use of Fundus Autofluorescence in Dry Age-Related Macular Degeneration. Kegkek, Nedime Sahinoglu; Cermet, Figen May 1, 2021 5617
Outlook Therapeutics is bringing a treatment for retinal disease to the market at the right time. Apr 30, 2021 1280
Incidence of endophthalmitis following intravitreal anti VEGF injections at a tertiary care hospital in Pakistan. Shaheen, Fiza; Awan, Muhammad Amer; Hafeez, Aiman; Haq, Aqdus; Zainab, Ramsha Report Apr 30, 2021 2552
IL-9 and IL-10 Single-Nucleotide Variants and Serum Levels in Age-Related Macular Degeneration in the Caucasian Population. Vilkeviciute, Alvita; Cebatoriene, Dzastina; Kriauciuniene, Loresa; Zemaitiene, Reda; Liutkeviciene, Apr 13, 2021 10665
Bausch + Lomb offers range of products for trying times. Apr 5, 2021 929
Thousands will go blind as eye appointments missed. EXCLUSIVE BY MARTIN BAGOT Health Editor Apr 5, 2021 215
Adverum Biotechnologies announces senior appointments for patient access. Mar 30, 2021 233
Lineage Cell says vitelliform maculopathy patient treated with OpRegen. Mar 29, 2021 336
Lineage Cell Therapeutics releases interim data on OpRegen for dry AMD. Clinical report Mar 23, 2021 462
Unity Biotechnology reports Q4 EPS (37c), consensus (47c). Financial report Mar 23, 2021 157
Assessment of Modified Patient Education Materials for People with Age-Related Macular Degeneration. Fortuna, Jennifer; Riddering, Anne; Shuster, Linda; Lopez-Jeng, Cassie Mar 22, 2021 7299
PENSIONER SALUTES CHARITY; Catherine's sight loss assistance proves vital. KARLA SINCLAIR Mar 17, 2021 749
HEALTH NEWS; Pollution linked to sight loss. DR MIRIAM STOPPARD Mar 16, 2021 152
Pollution linked to sight loss; HEALTH NEWS. DR MIRIAM STOPPARD Mar 16, 2021 152
Common HIV drugs may help prevent leading cause of vision loss. Mar 1, 2021 231
Living Life Fully with Macular Degeneration. Polak, Doris Winn Mar 1, 2021 265
Queue jumper attacks blind man. Feb 28, 2021 258
10 Ways to Improve Your Eyesight. Feb 25, 2021 808
Gyroscope Therapeutics Touts Positive Interim Data from Phase I/II FOCUS Trial of Investigational Gene Therapy GT005. Feb 16, 2021 540
Roche antibody shows promise for macular degeneration. Feb 15, 2021 551
Roche Reports Positive Faricimab New Phase 3 Study Results. Feb 12, 2021 199
Gemini Therapeutics Completes Enrollment in Phase 2a Trial of GEM103 in Dry Age-Related Macular Degeneration (AMD) in Patients with High-Risk Genetic Variants. Feb 11, 2021 634
Age-Related Macular Degeneration (AMD) Transmitochondrial Cybrids Protected from Cellular Damage and Death by Human Retinal Progenitor Cells (hRPCs). Yu, Jeffrey J.; Azzam, Daniel B.; Chwa, Marilyn; Schneider, Kevin; Cho, Jang-Hyeon; Hsiang, Chinhui; Feb 9, 2021 9435
New treatment on NHS can slow down eye disease. SONIA SHARMA Reporter sonia.sharma@reachplc.com Feb 8, 2021 657
Sight for sore eyes; new treatment could benefit sufferers of degenerative eye disease. SONIA SHARMA Reporter sonia.sharma@reachplc.com Feb 8, 2021 648
Imaging Hyperreflective Foci as an Inflammatory Biomarker after Anti-VEGF Treatment in Neovascular Age-Related Macular Degeneration Patients with Optical Coherence Tomography Angiography. Wu, Jing; Zhang, Chaoyang; Yang, Qian; Xie, Hai; Zhang, Jingting; Qiu, Qinghua; Liu, Kun; Luo, Dawei Report Feb 4, 2021 4805
SCIENCE AND VISION. Feb 1, 2021 196
How do you talk to your patients about AMD? Edwards, Richard; Oakley, Sarah Feb 1, 2021 3573
Genentech's Faricimab Meets Primary Endpoint in Two Global Phase III Studies. Jan 26, 2021 638
Study: Air pollution linked to irreversible sight loss. Jan 26, 2021 449
Roche's Faricimab Meets Primary Endpoint; Renews Contract With Sysmex. Jan 25, 2021 252
The Diagnostic Capability of Swept Source OCT Angiography in Treatment-Naive Exudative Neovascular Age-Related Macular Degeneration. Ahmed, Daniel; Stattin, Martin; Haas, Anna-Maria; Kickinger, Stefan; Gabriel, Maximilian; Graf, Alex Jan 1, 2021 4842
Pirfenidone Alleviates Choroidal Neovascular Fibrosis through TGF-ß /Smad Signaling Pathway. Gao, Chuang; Cao, Xin; Huang, Lili; Bao, Yueqi; Li, Tao; Di, Yue; Wu, Liucheng Jan 1, 2021 4838
Outcomes of Abrupt Switch to Bevacizumab of Patients Undergoing Aflibercept Intravitreal Injections for Neovascular Age-Related Macular Degeneration in a Tertiary Center in Lombardy, Italy: A Real-Life Retrospective Analysis. Randazzo, Alessandro; Raimondi, Raffaele; Fossati, Giovanni; Romano, Mary; Sorrentino, Tania; Castel Jan 1, 2021 2750
Investigation of Key Signaling Pathways Associating miR-204 and Common Retinopathies. Bereimipour, Ahmad; Satarian, Leila; Taleahmad, Sara Report Jan 1, 2021 6742
Short-Term Outcomes following “Switching” to Monthly Ranibizumab in Neovascular Age-Related Macular Degeneration Showing Insufficient Response to Bimonthly Aflibercept. Lee, Jong Suk; Kang, Hyun Goo; Lee, Christopher Seungkyu; Woo, Se Joon Jan 1, 2021 4365
Causes and Five-Year Proportion of New Irreversible Visual Impairment in Jinshan District, Shanghai, from 2009-2018. Li, Tao; Zhou, Xiaodong Jan 1, 2021 4030
OCT Biomarkers in Neovascular Age-Related Macular Degeneration: A Narrative Review. Metrangolo, Cristian; Donati, Simone; Mazzola, Marco; Fontanel, Liviana; Messina, Walter; D'alterio, Jan 1, 2021 11383
Mechanism of Nucleic Acid Sensing in Retinal Pigment Epithelium (RPE): RIG-I Mediates Type I Interferon Response in Human RPE. Schustak, Joshua; Twarog, Michael; Wu, Xiaoqiu; Wu, Henry Y.; Huang, Qian; Bao, Yi Jan 1, 2021 10036
Visual Function and Patient Satisfaction with Multifocal Intraocular Lenses in Patients with Glaucoma and Dry Age-Related Macular Degeneration. Sánchez-Sánchez, Carmen; Rementería-Capelo, Laureano A.; Puerto, Beatriz; López-Caballero, Cristina; Jan 1, 2021 4278
Polypoidal Choroidal Vasculopathy Diagnosis and Neovascular Activity Evaluation Using Optical Coherence Tomography Angiography. Azar, Georges; Vasseur, Vivien; Lahoud, Corinne; Favard, Catherine; De Bats, Flore; Cochereau, Isabe Report Jan 1, 2021 4234
Clinical Features, Prognosis, and Long-Term Response to Ranibizumab of Macular CNVs in Pattern Dystrophies Spectrum: A Pilot Study. Casillo, Lorenzo; Tricarico, Stefano; Contento, Laura; Vingolo, Enzo M. Jan 1, 2021 4818
Eyes that Do Not Meet the Eligibility Criteria of Clinical Trials on Age-Related Macular Degeneration: Proportion of the Real-World Patient Population and Reasons for Exclusion. Kim, Jae Hui; Kim, Jong Woo; Kim, Chul Gu Jan 1, 2021 6064
Clinical Characteristics of Neovascular Age-Related Macular Degeneration without Typical Drusen. Kamao, Hiroyuki; Goto, Katsutoshi; Matsuno, Kento; Mizukawa, Kenichi; Miki, Atsushi; Kiryu, Junichi Jan 1, 2021 5651
Non-infectious Intraocular Inflammation Following Intravitreal Anti-Vascular Endothelial Growth Factor Injection. Kaya, Mahmut; Oner, Ferit Hakan; Yagci, Betul Akbulut; Atas, Ferdane; Ozturk, Taylan Jan 1, 2021 3793
Subretinal Coapplication of Tissue Plasminogen Activator and Bevacizumab with Concurrent Pneumatic Displacement for Submacular Hemorrhages Secondary to Neovascular Age-Related Macular Degeneration. Avci, Remzi; Yildiz, Aysegul Mavi; Cinar, Esat; Yilmaz, Sami; Kucukerdonmez, Cem; Akalp, Fatma Duriy Jan 1, 2021 4452
MicroRNA-27a Promotes Oxidative-Induced RPE Cell Death through Targeting FOXO1. Ren, Chengda; Hu, Weinan; Wei, Qingquan; Cai, Wenting; Jin, Huizi; Yu, Donghui; Liu, Chang Report Jan 1, 2021 7974
Janssen Acquires Rights to Eye Disorder Gene Therapy from Hemera Biosciences. Dec 3, 2020 166
Comparative Analysis of the Clinical Features and Long-Term Outcomes of Pachychoroid Neovasculopathy and Type 1 Neovascular Age-Related Macular Degeneration. You, Jong In; Kim, Kiyoung Dec 3, 2020 4081
How technology can help to future-proof a wet AMD service. Powell, Selina Dec 1, 2020 247
Light for sight. Elks, David Dec 1, 2020 3040
Fixed Regimen Treatment in Unselected Naïve Patients Cohort with Neovascular Age-Related Macular Degeneration. Casaroli-Marano, Ricardo P.; Bernal-Morales, Carolina; Chamorro-López, Lillian; Dotti-Boada, Marina; Nov 21, 2020 5189
Xbrane completes patient enrolment in phase III trial of biosimilar candidate Xlucane. Nov 12, 2020 163
Xbrane completes patient enrolment in phase III trial of biosimilar candidate Xlucane. Nov 12, 2020 158
Xbrane completes patient enrolment in phase III trial of biosimilar candidate Xlucane. Nov 12, 2020 162
Lineage Cell Therapeutics Completes Patient Enrollment in Phase 1/2a Clinical Study of OpRegen Cell Therapy for the Treatment of Dry Age-related Macular Degeneration. Clinical report Nov 11, 2020 595
Bausch + Lomb's core offerings meet array of vision needs. Nov 9, 2020 808
The Prevalence of Undiagnosed Age-Related Sight-Threatening Diseases in Self-Proclaimed Healthy Individuals. Lemmens, Sophie; Barbosa Breda, João; Van Keer, Karel; Jacobs, Tine; Van Landeghem, Ruben; De Boever Clinical report Nov 7, 2020 6857
Ways to Improve Your Eyesight. Oct 29, 2020 1027
First Patient Received Investigational Gene Therapy GT005 Via Orbit Subretinal Delivery System in Ongoing Phase I/II FOCUS Trial. Oct 28, 2020 368
Guardion Health Sciences announces investigator-initiated trial of Lumega-Z. Oct 26, 2020 311
Evaluation of Anxiety Levels in Patients Undergoing Intravitreal Injections and Associated Risk Factors Related to the Disease. Herranz-Heras, Juan-Carlos; de-Pablo-Cabrera, Almudena; Alonso-Martín, Beatriz; de-Lucas-Viejo, Beat Oct 21, 2020 4654
Luteolin Attenuates IL-1ß -Induced THP-1 Adhesion to ARPE-19 Cells via Suppression of NF-? B and MAPK Pathways. Huang, Wen-Chung; Liou, Chian-Jiun; Shen, Szu-Chuan; Hu, Sindy; Hsiao, Chien-Yu; Wu, Shu-Ju Oct 16, 2020 6779
Alzheimer's Disease as a Result of Stimulus Reduction in a GABA-A-Deficient Brain: A Neurocomputational Model. Aguiar-Furucho, Mariana Antonia; Peláez, Francisco Javier Ropero Oct 14, 2020 17608
Optician backs no smoking and alcohol challenges. Oct 14, 2020 374
Outlook Therapeutics initiates supplemental open-label safety study of ONS-5010. Oct 13, 2020 404
Age-Related Macular Degeneration and Cardiovascular Diseases and Risk Factors Associated with It--A Cross Sectional Study in Kerala. Deepa, M.G.; Sija, S.; Jacob, K.K.; Rajeevan, P. Oct 12, 2020 3582
Phillyrin Mitigates Apoptosis and Oxidative Stress in Hydrogen Peroxide-Treated RPE Cells through Activation of the Nrf2 Signaling Pathway. Du, Yuanyuan; You, Longtai; Ni, Boran; Sai, Na; Wang, Wenping; Sun, Mingyi; Xu, Rui Oct 12, 2020 8473
Help your eyes with 'Stoptober' annual challenge. Oct 7, 2020 248
Hinsdale-Based Visible Genomics Announces Four New Appointments to Board of Clinical Advisors. Creative Marketing Associates Oct 6, 2020 420
Ocugen engages Kemwell Biopharma for cGMP manufacture of OCU200. Oct 6, 2020 216
Reporting of Safety Events during Anti-VEGF Treatment: Pharmacovigilance in a Noninterventional Trial. Ziemssen, Focke; Hammer, Thomas; Grueb, Matthias; Mueller, Bettina; Berk, Hüsnü; Gamulescu, Maria-An Clinical report Oct 6, 2020 9574
Fortified S-Allyl L-Cysteine: Animal Safety, Effect on Retinal Ischemia, and Role of Wnt in the Underlying Therapeutic Mechanism. Chao, Windsor Wen-Jin; Chen, Yu-Kuang; Chao, Howard Wen-Haur; Pan, Wynn Hwai-Tzong; Chao, Hsiao-Ming Oct 5, 2020 7761
Eye up challenge for your health. Oct 5, 2020 199
Novartis Notes Phase III Trial Showing Improved Beovu Treatment. Oct 5, 2020 221
Kodiak Sciences: First patients treated in Phase 3 Studies of KSI-301. Oct 5, 2020 156
Eyevensys Receives FDA Orphan Drug Designation for EYS611 for Treatment of Retinitis Pigmentosa. Oct 5, 2020 620
Apellis announces results of post hoc analysis of Phase 2 FILLY study. Oct 4, 2020 238
Visible Genomics Announces Four New Appointments to Board of Clinical Advisors. Creative Marketing Associates Oct 2, 2020 952
Lineage Cell Therapeutics busy working on treatments relating to Dry AMD and spinal cord injury. Oct 2, 2020 158
Periodontal Disease and Age-Related Macular Degeneration: A Meta-Analysis of 112,240 Participants. Lv, Xuewen; Li, Weiqi; Fang, Zhiyu; Xue, Xiaofei; Pan, Chunling Report Sep 29, 2020 5995
Does Cataract Surgery Improve the Progression of Age-Related Macular Degeneration? A Meta-Analysis. Liu, Yuanyuan; Cai, Qinhua Sep 27, 2020 6893
Astellas Pharma collaborates with University of Pittsburgh. Sep 25, 2020 257
Astellas Pharma collaborates with University of Pittsburgh. Sep 25, 2020 253
Gyroscope Therapeutics Granted FDA Fast Track Designation for GT005, an Investigational Gene Therapy for Dry Age-Related Macular Degeneration. Sep 22, 2020 300
Exploring Associations Between Health Literacy and Visual Impairment in Older Adults with Age-Related Macular Degeneration (AMD). Fortuna, Jennifer Sep 22, 2020 4322
Bausch Health to Acquire Option to Purchase All Ophthalmology Assets of Allegro Ophthalmics. Sep 21, 2020 404
Visible Genomics launches DNA age-related macular degeneration testing. Submitted by Creative Marketing Associates Sep 17, 2020 541
Visible Genomics Launches DNA Age-Related Macular Degeneration Testing. Creative Marketing Associates Sep 16, 2020 547
Readers continue to worry about COVID-19 Doctors: Soft drusen can lead to macular degeneration. Sep 14, 2020 1009
Drusen severity depends on the type. Dr. Eve Glazier and Dr. Elizabeth Ko Sep 14, 2020 554
Subgroups and Features of Poor Responders to Anti-Vascular Endothelial Growth Factor Treatment in Eyes with Neovascular Age-Related Macular Degeneration. Baris, Mine Esen; Mentes, Jale; Afrashi, Filiz; Nalcaci, Serhad; Akkin, Cezmi Clinical report Sep 1, 2020 5283
Identification of Key Genes and Pathways Associated with Age-Related Macular Degeneration. Zhang, Junyu; Zhou, Yu Aug 31, 2020 5578
Long-Term Visual Outcomes for a Treat-and-Extend Antivascular Endothelial Growth Factor Regimen in Eyes with Neovascular Age-Related Macular Degeneration: Up to Seven-Year Follow-Up. Javidi, Simon; Dirani, Ali; Antaki, Fares; Saab, Marc; Rahali, Sofiane; Cordahi, Ghassan Clinical report Aug 31, 2020 9050
The Efficacy of Conbercept in Polypoidal Choroidal Vasculopathy: A Systematic Review. Wang, Yimin; Shen, Mengxi; Cheng, Jinwei; Sun, Xiaodong; Kaiser, Peter K. Report Aug 31, 2020 7296
Effect of the Duration of Intraretinal or Subretinal Fluid on the Response to Treatment in Undertreated Age-Related Macular Degeneration. Yoshida, Izumi; Sakamoto, Masashi; Sakai, Asao; Maeno, Takatoshi Aug 31, 2020 5395
Automatic Quantification Software for Geographic Atrophy Associated with Age-Related Macular Degeneration: A Validation Study. Ruiz-Moreno, Jose M.; Ruiz-Medrano, Jorge; Lugo, Francisco; Sirvent, Belen; Flores-Moreno, Ignacio Aug 31, 2020 3899
Detrimental Effects of UVB on Retinal Pigment Epithelial Cells and Its Role in Age-Related Macular Degeneration. Mahendra, Camille Keisha; Tan, Loh Teng Hern; Pusparajah, Priyia; Htar, Thet Thet; Chuah, Lay-Hong; Aug 31, 2020 20176
Protective Effect of Metformin against Hydrogen Peroxide-Induced Oxidative Damage in Human Retinal Pigment Epithelial (RPE) Cells by Enhancing Autophagy through Activation of AMPK Pathway. Zhao, Xia; Liu, Linlin; Jiang, Yizhou; Silva, Marta; Zhen, Xuechu; Zheng, Wenhua Aug 31, 2020 8277
Autophagy in Age-Related Macular Degeneration: A Regulatory Mechanism of Oxidative Stress. Zhang, Zi-Yuan; Bao, Xiao-Li; Cong, Yun-Yi; Fan, Bin; Li, Guang-Yu Aug 31, 2020 10274
Autophagy Upregulation by the TFEB Inducer Trehalose Protects against Oxidative Damage and Cell Death Associated with NRF2 Inhibition in Human RPE Cells. Abokyi, Samuel; Shan, Sze wan; To, Chi-ho; Chan, Henry Ho-lung; Tse, Dennis Yan-yin Aug 31, 2020 10365
Tribulus terrestris Ameliorates Oxidative Stress-Induced ARPE-19 Cell Injury through the PI3K/Akt-Nrf2 Signaling Pathway. Yuan, Zhenli; Du, Weiwei; He, Xiangdong; Zhang, Donglei; He, Wei Aug 31, 2020 9331
New Understanding of Genetic Changes in the Eye. Aug 26, 2020 209
Outlook Therapeutics reports topline results from NORSE 1 study. Aug 26, 2020 432
Gyroscope Therapeutics Initiates Phase II Programme Evaluating its Investigational Gene Therapy, GT005, for Dry Age-Related Macular Degeneration. Aug 13, 2020 671
Kodiak Sciences reports Q2 EPS (58c), consensus (66c). Financial report Aug 10, 2020 395
Regenxbio sees starting RGX-314 subretinal delivery pivotal program by end 2020. Aug 4, 2020 256
OCT findings in age-related macular degeneration. Epshtein, Daniel Aug 1, 2020 599
Metformin Protects ARPE-19 Cells from Glyoxal-Induced Oxidative Stress. Qu, Sichang; Zhang, Chaoyang; Liu, Dandan; Wu, Jing; Tian, Haibin; Lu, Lixia; Xu, Guo-Tong; Liu, Fan Jul 31, 2020 7174
Corrigendum to "Cathepsin B pH-Dependent Activity Is Involved in Lysosomal Dysregulation in Atrophic Age-Related Macular Degeneration". Voisin, Audrey; Monville, Christelle; Plancheron, Alexandra; Bere, Emile; Gaillard, Afsaneh; Levezie Correction notice Jul 31, 2020 241
Renin-Angiotensin System Inhibitor Usage and Age-Related Macular Degeneration among Hypertensive Patients: Results from the National Health and Nutrition Examination Survey, 2005-2008. Ren, Chi; Liu, Weiming; Yin, Xue; Zhang, Bingyu; Lu, Peirong Jul 31, 2020 6579
Use of Imaging Modalities in Real Life: Impact on Visual Acuity Outcomes of Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration in Germany. Wachtlin, Joachim; Spital, Georg; Schmitz-Valckenberg, Steffen; Liakopoulos, Sandra; Vogeler, Jessic Clinical report Jul 31, 2020 6660
Novartis Sees Positive Beovu Analysis Results; Sandoz Plans Investment. Jul 27, 2020 386
Clearside Biomedical announces multiple presentations at ASRS Annual Meeting. Jul 27, 2020 636
NGM Biopharmaceuticals initiates Phase 2 CATALINA study of NGM621. Jul 27, 2020 210
Genentech says Archway study data supports 'favorable' benefit-risk profile. Jul 22, 2020 468
Keep an eye on the light and your sight; It's not just your skin you need to protect in the sun - UV exposure is a gateway to age-related macular degeneration, the leading cause of sight loss in the UK. Here optometrist Francesca Marchetti reveals how you can look after your vision this summer. Francesca Marchetti Jul 21, 2020 778
Look out for your eyesight this summer; It's not just your skin you need to protect in the sun - UV exposure is a gateway to age-related macular degeneration, the leading cause of sight loss in the UK. Here optometrist Francesca Marchetti reveals how you can look after your vision this summer. Jul 21, 2020 1050
Look out for your eyesight this summer; It's not just your skin you need to protect in the sun - UV exposure is a gateway to age-related macular degeneration, the leading cause of sight loss in the UK. Here optometrist Francesca Marchetti reveals how you can look after your vision this summer. Francesca Marchetti Jul 21, 2020 1054
Blind ex-Navy man urges runners to join in challenge. LISA O'BRIEN lisa.obrien@mnamedia.co.uk Jul 11, 2020 370
Kodiak Sciences reports 'promising' safety data from KSI-301 Phase 1b study. Jul 10, 2020 283
First Patient Dosed in Second Zimura Phase 3 Clinical Trial for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration. Jul 2, 2020 513
Stargardt Disease and Approaches to Learning for Individuals with This Condition. Davis, Alexis Poe; Bullard-Maxwell, Amanda; Stone-Hernandez, Regina; Chiarolanzio, Emily; Griffin, H Report Jul 1, 2020 3463
Effect of Repeated Intravitreal Ranibizumab and Aflibercept Injections on the Cornea in Patients with Age-Related Macular Degeneration. Urban, Beata; Szwabowicz, Magdalena; Bakunowicz-Lazarczyk, Alina Jun 30, 2020 5135
Cabozantinib, a Multityrosine Kinase Inhibitor of MET and VEGF Receptors Which Suppresses Mouse Laser-Induced Choroidal Neovascularization. Zhang, Xiaoli; Zhu, Manhui; Xie, Laiqing; Sun, Xiaodong; Xu, Jiaowen; Guo, Yang; Liu, Dong; Shi, Yun Jun 30, 2020 7087
Bioinformatical Analysis of miRNA-mRNA Interaction Network Underlying Macrophage Aging and Cholesterol-Responsive Difference between Young and Aged Macrophages. Li, Jianqing; Yin, Xue; Zhang, Bingyu; Li, Chen; Lu, Peirong Jun 30, 2020 4909
Lineage Re-Starts Enrollment In Clinical Study Of Treatment For Dry AMD. Jun 29, 2020 845
Allergan and Molecular Partners receive FDA response regarding Abicipar pegol for neovascular AMD. Jun 26, 2020 188
Allergan and Molecular Partners receive FDA response regarding Abicipar pegol for neovascular AMD. Jun 26, 2020 184
Lineage Cell Therapeutics reinitiates patient enrollment in OpRegen study. Clinical report Jun 18, 2020 176
Clearside Biomedical announce presentations at ARVO 2020 meeting. Jun 17, 2020 529
Outlook Therapeutics expects topline results from NORSE 1 study in August. Jun 17, 2020 510
Iveric bio announces 18-month Zimura trial data. Jun 15, 2020 451
Regeneration Of Retinal Tissue In Dry AMD Patient. Jun 15, 2020 709
Novartis Adds Warning To Beovu Label In US After Safety Reports. Jun 11, 2020 403
Lineage Cell Therapeutics reports findings from OpRegen study. Jun 1, 2020 330

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |